TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 33542729

Group type: EXPERIMENTAL
Intervention: HF‐rTMS (10.0 Hz over ipsilesional primary motor cortex for 10 consecutive days)
Number of subjects: 33

Group type: EXPERIMENTAL
Intervention: LF‐rTMS (1.0 Hz over contralesional primary motor cortex for 10 consecutive days)
Number of subjects: 33

Group type: COMPARATOR
Intervention: Sham group
Number of subjects: 33
Study: 32270483

Group type: EXPERIMENTAL
Intervention: High-target mean arterial pressure (70-80 mm Hg)
Number of subjects: 197

Group type: COMPARATOR
Intervention: Low-target mean arterial pressure (40-50 mm Hg)
Number of subjects: 197
Study: 36311634

Group type: COMPARATOR
Intervention: High-frequency group (HFG, 50 Hz)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Medium-frequency group (MFG, 25 Hz)
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: Control group (CG, 0 Hz)
Number of subjects: 38
Study: 34476047

Group type: EXPERIMENTAL
Intervention: Debonding plier (DP)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ligature cutter (LC)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Thermal method (TM)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Ultrasonic scaler (US)
Number of subjects: 80
Study: 34530477

Group type: EXPERIMENTAL
Intervention: Intraoperative technology (IT) including computer-assisted navigation (CAN) and robot-assisted surgery (RA)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Conventional TKA (control group)
Number of subjects: 327
Study: 33473021

Group type: EXPERIMENTAL
Intervention: Parenteral iron dextran
Number of subjects: 140

Group type: COMPARATOR
Intervention: Control (no iron replacement)
Number of subjects: 140
Study: 32360827

Group type: EXPERIMENTAL
Intervention: US‐Ax (axillary vein puncture guided by ultrasound)
Number of subjects: 88

Group type: COMPARATOR
Intervention: CV (cephalic vein dissection)
Number of subjects: 88

Group type: EXPERIMENTAL
Intervention: US‐Ax
Number of subjects: 88

Group type: COMPARATOR
Intervention: CV
Number of subjects: 88
Study: 33104939

Group type: EXPERIMENTAL
Intervention: Smartwatch
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Smart bracelet
Number of subjects: 73

Group type: COMPARATOR
Intervention: Mobile app
Number of subjects: 73
Study: 36347619

Group type: EXPERIMENTAL
Intervention: Weight-based protocol (Group C, full body)
Number of subjects: 1817

Group type: EXPERIMENTAL
Intervention: Weight-based protocol (Group D, half body)
Number of subjects: 1817

Group type: COMPARATOR
Intervention: Conventional protocol (Group A, full body)
Number of subjects: 1817

Group type: COMPARATOR
Intervention: Conventional protocol (Group B, half body)
Number of subjects: 1817
Study: 614284972

Group type: EXPERIMENTAL
Intervention: Smartphone application-delivered notched music therapy and Ginkgo biloba for 3 months
Number of subjects: 26

Group type: EXPERIMENTAL
Intervention: Initial THI score
Number of subjects: 26
Study: 35102532

Group type: EXPERIMENTAL
Intervention: Amiodarone
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Implantable Cardioverter-Defibrillator (ICD)
Number of subjects: 1000

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1000
Study: 32956506

Group type: EXPERIMENTAL
Intervention: Protocol A (20 ml 2% lidocaine + 10 ml 8.4% sodium bicarbonate)
Number of subjects: 116

Group type: COMPARATOR
Intervention: Protocol B (20 ml 2% lidocaine + 10 ml 0.9% saline solution)
Number of subjects: 116

Group type: EXPERIMENTAL
Intervention: Both Protocols
Number of subjects: 116
Study: 35191838

Group type: EXPERIMENTAL
Intervention: FFR-guided percutaneous coronary intervention (PCI)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Angiography-guided percutaneous coronary intervention (PCI)
Number of subjects: 0
Study: 32829410

Group type: EXPERIMENTAL
Intervention: Switch to integrase strand transfer inhibitors (INSTIs) including elvitegravir or raltegravir
Number of subjects: 523

Group type: COMPARATOR
Intervention: Efavirenz with tenofovir disoproxil fumarate
Number of subjects: 523

Group type: COMPARATOR
Intervention: Efavirenz with abacavir
Number of subjects: 523
Study: 36089595

Group type: EXPERIMENTAL
Intervention: diacerein (50mg twice daily)
Number of subjects: 260

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 260
Study: 32912615

Group type: EXPERIMENTAL
Intervention: Anastrozole
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Letrozole
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 0
Study: 35944566

Group type: EXPERIMENTAL
Intervention: IPACK block
Number of subjects: 96

Group type: COMPARATOR
Intervention: No block (Control)
Number of subjects: 96
Study: 33510284

Group type: EXPERIMENTAL
Intervention: Nomogram based on independent predictors (body mass index, serum albumin level, hypertension, number of total dissected axillary lymph nodes, ratio of positive axillary lymph nodes)
Number of subjects: 972

Group type: EXPERIMENTAL
Intervention: Training cohort
Number of subjects: 972

Group type: EXPERIMENTAL
Intervention: Validation cohort
Number of subjects: 972
Study: 32579779

Group type: EXPERIMENTAL
Intervention: Preoperative ultrasound guided parasternal block with 0.25% bupivacaine (4 mL into anterior intercostal spaces)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Postoperative parasternal intercostal block with 0.25% bupivacaine (4 mL into anterior intercostal spaces)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Preoperative ultrasound guided parasternal block
Number of subjects: 90

Group type: COMPARATOR
Intervention: Postoperative parasternal intercostal block
Number of subjects: 90
Study: 35760338

Group type: EXPERIMENTAL
Intervention: CPT‐SMART (Cognitive Processing Therapy for PTSD, smoking cessation counseling, pharmacotherapy, and contingency management)
Number of subjects: 120

Group type: COMPARATOR
Intervention: Yoked comparison group (monetary reinforcement matched to the participant)
Number of subjects: 120
Study: 33687692

Group type: EXPERIMENTAL
Intervention: Crisis checklists
Number of subjects: 24

Group type: COMPARATOR
Intervention: No checklist
Number of subjects: 24
Study: 32417119

Group type: EXPERIMENTAL
Intervention: GL+CBI (capacity-building intervention)
Number of subjects: 51

Group type: COMPARATOR
Intervention: GL-ONLY (comparison group)
Number of subjects: 51

Group type: COMPARATOR
Intervention: NO-GL (no guidelines)
Number of subjects: 51
Study: 35598084

Group type: EXPERIMENTAL
Intervention: 20 mL 0.2% Ropivacaine with dexamethasone 8 mg (Group R + D)
Number of subjects: 64

Group type: COMPARATOR
Intervention: 20 mL 0.2% Ropivacaine (Group R)
Number of subjects: 64

Group type: EXPERIMENTAL
Intervention: Group R + D
Number of subjects: 64

Group type: COMPARATOR
Intervention: Group R
Number of subjects: 64
Study: 33721441

Group type: EXPERIMENTAL
Intervention: Nimotuzumab + PF induction chemotherapy (NPF group)
Number of subjects: 126

Group type: COMPARATOR
Intervention: TPF induction chemotherapy (TPF group)
Number of subjects: 126
Study: 33672151

Group type: EXPERIMENTAL
Intervention: Smoke-free contract implementation
Number of subjects: 2015

Group type: EXPERIMENTAL
Intervention: Social gradient effect among girls
Number of subjects: 2015

Group type: EXPERIMENTAL
Intervention: Odds of boys having a smoke-free contract
Number of subjects: 2015
Study: 33940983

Group type: EXPERIMENTAL
Intervention: Mobile produce market program (Food on the Move) with SNAP incentive program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Fresh to You mobile market program
Number of subjects: 0

Group type: COMPARATOR
Intervention: Live Well, Viva Bien mobile market program
Number of subjects: 0
Study: 33727509

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin patch (10 mg over 24 h, with a second patch after 1 h if contractions persisted)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Oral nifedipine (20 mg loading dose, followed by 10 mg thrice daily if contractions suppressed)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Transdermal nitroglycerin patch
Number of subjects: 50

Group type: COMPARATOR
Intervention: Oral nifedipine
Number of subjects: 50
Study: 32898095

Group type: EXPERIMENTAL
Intervention: FineVision POD F IOL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: RayOne Trifocal IOL
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: AcrySof IQ PanOptix IOL
Number of subjects: 45

Group type: COMPARATOR
Intervention: All IOLs (combined)
Number of subjects: 45
Study: 35662230

Group type: EXPERIMENTAL
Intervention: Compression therapy (not specified dosage or duration)
Number of subjects: 58

Group type: COMPARATOR
Intervention: Standard care (not specified)
Number of subjects: 58
Study: 33069653

Group type: EXPERIMENTAL
Intervention: Transcatheter mitral valve repair (TMVr)
Number of subjects: 141

Group type: EXPERIMENTAL
Intervention: Successful TMVr
Number of subjects: 141
Study: 33120078

Group type: EXPERIMENTAL
Intervention: Compound 34 (naphthyridinone scaffold)
Number of subjects: 1
Study: 35167198

Group type: EXPERIMENTAL
Intervention: Hexetidine (0.1% w/v)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: H2O2 (1.5%)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo-control (de-mineralized sterile water)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Thymol (0.063% w/v)
Number of subjects: 66
Study: 34334383

Group type: EXPERIMENTAL
Intervention: Radiomics signature (RS) > 0.61
Number of subjects: 77

Group type: EXPERIMENTAL
Intervention: Radiomics nomogram
Number of subjects: 77
Study: 32138765

Group type: EXPERIMENTAL
Intervention: Vitamin D/calcium milk fortification and periodontal therapy
Number of subjects: 70
Study: 35136981

Group type: EXPERIMENTAL
Intervention: Rituximab
Number of subjects: 54

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study: 34003122

Group type: EXPERIMENTAL
Intervention: Standard care with classical music intervention before and during the biopsy procedure
Number of subjects: 64

Group type: COMPARATOR
Intervention: Standard care only
Number of subjects: 64
Study: 35649707

Group type: EXPERIMENTAL
Intervention: HEAVY (high-load strengthening exercise, supervised twice/week)
Number of subjects: 100

Group type: COMPARATOR
Intervention: LIGHT (low-load strengthening exercise, supervised three times/week)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: HEAVY
Number of subjects: 100

Group type: COMPARATOR
Intervention: LIGHT
Number of subjects: 100
Study: 34914446

Group type: EXPERIMENTAL
Intervention: Tuning in to Kids (TIK) parenting program, 6-week intervention
Number of subjects: 104

Group type: COMPARATOR
Intervention: Waitlist control group (no intervention initially)
Number of subjects: 104
Study: 33249347

Group type: EXPERIMENTAL
Intervention: Treatment group received constant TENS over the hamstring muscles during exercises.
Number of subjects: 19

Group type: COMPARATOR
Intervention: Sham group was exposed to a brief TENS current.
Number of subjects: 19
Study: 33107921

Group type: EXPERIMENTAL
Intervention: Real electroacupuncture
Number of subjects: 121

Group type: COMPARATOR
Intervention: Sham electroacupuncture
Number of subjects: 121
Study: 35219521

Group type: EXPERIMENTAL
Intervention: High tidal volume (HTV) ventilation (>10 mL/kg predicted body weight)
Number of subjects: 780

Group type: COMPARATOR
Intervention: Non-high tidal volume (non-HTV) ventilation (≤10 mL/kg predicted body weight)
Number of subjects: 780
Study: 32564493

Group type: EXPERIMENTAL
Intervention: Quilting suture
Number of subjects: 140

Group type: COMPARATOR
Intervention: Conventional closure
Number of subjects: 140
Study: 33514490

Group type: EXPERIMENTAL
Intervention: DAPT
Number of subjects: 1086

Group type: COMPARATOR
Intervention: SAPT
Number of subjects: 1086
Study: 33449481

Group type: EXPERIMENTAL
Intervention: Nitrile gloves and mask
Number of subjects: 34

Group type: COMPARATOR
Intervention: Surgical mask
Number of subjects: 34
Study: 32228343

Group type: EXPERIMENTAL
Intervention: Ursodeoxycholic acid (UDCA) 500 mg/day for 6 months after LSG
Number of subjects: 280

Group type: COMPARATOR
Intervention: No UDCA treatment (pre-2015 protocol)
Number of subjects: 280
Study: 33790084

Group type: EXPERIMENTAL
Intervention: Foam from SM‐4
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Foams from 4% and 1% SM‐4
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Drug-containing foam formulations (benzydamine, dexamethasone, allopurinol, rebamipide) prepared with 1–4% SM‐4
Number of subjects: 0
Study: 33269838

Group type: EXPERIMENTAL
Intervention: Combination of 'kidney three-needle' therapy and fire needling therapy
Number of subjects: 60

Group type: COMPARATOR
Intervention: Common acupuncture
Number of subjects: 60
Study: 35987694

Group type: EXPERIMENTAL
Intervention: Closed face shields with surgical face masks
Number of subjects: 316

Group type: COMPARATOR
Intervention: Surgical face masks alone (active control)
Number of subjects: 316
Study: 34464490

Group type: EXPERIMENTAL
Intervention: Individual cognitive behavioral therapy (CBT)
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: CBT with parent involvement
Number of subjects: 254

Group type: EXPERIMENTAL
Intervention: Parent psychological control
Number of subjects: 254

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 254
Study: 32072597

Group type: EXPERIMENTAL
Intervention: Masking in pragmatic randomized clinical trials (pRCTs)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 33397386

Group type: EXPERIMENTAL
Intervention: Patient Advisors (PAs) integrated into clinical oncology teams
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 32810574

Group type: EXPERIMENTAL
Intervention: Menu with sustainability labels indicating environmental impact
Number of subjects: 0

Group type: COMPARATOR
Intervention: Menu without sustainability labels
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Veggie burger labeled as especially sustainable
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Veggie burger labeled as especially tasty
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sustainability and taste manipulations
Number of subjects: 0
Study: 35358738

Group type: EXPERIMENTAL
Intervention: High-dose oxytocin
Number of subjects: 140

Group type: COMPARATOR
Intervention: Low-dose oxytocin
Number of subjects: 140
Study: 32203569

Group type: EXPERIMENTAL
Intervention: Integrated collaborative care intervention for 12 months
Number of subjects: 409

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 409

Group type: EXPERIMENTAL
Intervention: Integrated collaborative care intervention
Number of subjects: 409
Study: 32651141

Group type: EXPERIMENTAL
Intervention: 0.75 g ZM in 10 mL oxymel
Number of subjects: 3

Group type: EXPERIMENTAL
Intervention: 1.5 g ZM in 10 mL oxymel
Number of subjects: 3

Group type: COMPARATOR
Intervention: 10 mL of oxymel
Number of subjects: 3
Study: 35365594

Group type: EXPERIMENTAL
Intervention: MK-7 (200 mcg/day)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 60
Study: 33974018

Group type: EXPERIMENTAL
Intervention: Antimicrobial therapy (co-trimoxazole or doxycycline)
Number of subjects: 513

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Co-trimoxazole
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Serious adverse events (respiratory events)
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Serious adverse events (infections)
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Adverse events of special interest (diarrhea)
Number of subjects: 513

Group type: EXPERIMENTAL
Intervention: Adverse events of special interest (rash)
Number of subjects: 513
Study: 35500958

Group type: EXPERIMENTAL
Intervention: Mulligan traction straight leg raise (TSLR) technique
Number of subjects: 22

Group type: COMPARATOR
Intervention: Static stretching
Number of subjects: 22
Study: 34029448

Group type: EXPERIMENTAL
Intervention: High Dose (HD) glucagon infusion (25 ng/kg/min)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: Low Dose (LD) glucagon infusion (12.5 ng/kg/min)
Number of subjects: 31

Group type: COMPARATOR
Intervention: Placebo infusion
Number of subjects: 31
Study: 34747336

Group type: EXPERIMENTAL
Intervention: Indoor plants
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Guided meditation
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control rest‐break
Number of subjects: 60
Study: 34555671

Group type: EXPERIMENTAL
Intervention: Rocktape plus exercise
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham taping plus exercise
Number of subjects: 36
Study: 35724842

Group type: EXPERIMENTAL
Intervention: mHealth only (phone text messaging and digital self-weighing)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: mHealth intervention plus CHW behavioral phone counseling (mHealth+CHW)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Assessment only
Number of subjects: 0
Study: 34932433

Group type: EXPERIMENTAL
Intervention: Restricted Group (sleeping in a supine position)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unrestricted Group (no restriction on sleeping position)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Unrestricted Group
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Restricted Group
Number of subjects: 0
Study: 32066284

Group type: EXPERIMENTAL
Intervention: Finasteride
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Minoxidil
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: PRP (platelet-rich plasma)
Number of subjects: 0
Study: 34092633

Group type: EXPERIMENTAL
Intervention: Multidomain intervention (n=164)
Number of subjects: 327

Group type: COMPARATOR
Intervention: Usual care (Control group, n=164)
Number of subjects: 327
Study: 32619209

Group type: EXPERIMENTAL
Intervention: Motorcycle riding behavior questionnaire (MRBQ)
Number of subjects: 340

Group type: EXPERIMENTAL
Intervention: Independent predictors of risky riding score
Number of subjects: 340
Study: 35250440

Group type: EXPERIMENTAL
Intervention: 1‐Octen‐3‐ol (familiar neutral odor)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Pyridine
Number of subjects: 23

Group type: COMPARATOR
Intervention: Water (odorless stimulus)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 1‐Octen‐3‐ol
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: 1‐Octen‐3‐ol and Pyridine
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Olfactory behavioral response
Number of subjects: 23
Study: 32249306

Group type: EXPERIMENTAL
Intervention: Natural Language Processing (NLP) analysis on pain-related abstracts
Number of subjects: 200000

Group type: EXPERIMENTAL
Intervention: Deep learning-based gated recurrent units abstract generation model
Number of subjects: 200000
Study: 35876511

Group type: EXPERIMENTAL
Intervention: CO2 fiber laser vaporization
Number of subjects: 0

Group type: COMPARATOR
Intervention: Cystectomy
Number of subjects: 0
Study: 33144331

Group type: EXPERIMENTAL
Intervention: 10 mg [14C]lemborexant (100 µCi)
Number of subjects: 0
Study: 32725642

Group type: EXPERIMENTAL
Intervention: Intervention for sleep disorders in dementia
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Delphi consensus process
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Distribution-based values
Number of subjects: 62

Group type: EXPERIMENTAL
Intervention: Correlation with DEMQOL-Proxy
Number of subjects: 62
Study: 34092191

Group type: EXPERIMENTAL
Intervention: Beta-alanine (6.4 g·day‐1 for 28 days)
Number of subjects: 17

Group type: COMPARATOR
Intervention: Placebo (maltodextrin)
Number of subjects: 17

Group type: EXPERIMENTAL
Intervention: Beta-alanine
Number of subjects: 17

Group type: COMPARATOR
Intervention: Beta-alanine and Placebo
Number of subjects: 17
Study: 32474744

Group type: EXPERIMENTAL
Intervention: Zoledronate
Number of subjects: 756

Group type: COMPARATOR
Intervention: Denosumab
Number of subjects: 756
Study: 34184418

Group type: EXPERIMENTAL
Intervention: LY01008
Number of subjects: 649

Group type: COMPARATOR
Intervention: Avastin
Number of subjects: 649

Group type: EXPERIMENTAL
Intervention: LY01008 and Avastin
Number of subjects: 649
Study: 35584890

Group type: EXPERIMENTAL
Intervention: Salutogenic Model-Based Frailty Prevention Program (SAFRAPP)
Number of subjects: 84

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 84
Study: 34868479

Group type: COMPARATOR
Intervention: Unguided online cognitive-behavioral therapy (CBT)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Guided online cognitive-behavioral therapy (CBT)
Number of subjects: 0
Study: 33528893

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HCQ) 400 mg/day for 13 weeks
Number of subjects: 100

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study: 35457330

Group type: EXPERIMENTAL
Intervention: L-arginine (8 gr daily for 8 days)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: L-citrulline (8 gr daily for 8 days)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo (8 gr daily for 8 days)
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: All groups (L-arginine, L-citrulline, and placebo)
Number of subjects: 15
Study: 33337956

Group type: EXPERIMENTAL
Intervention: Flywheel inertia at 0.029 kg·m2
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Flywheel inertia at 0.061 kg·m2
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Flywheel inertia at 0.089 kg·m2
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Flywheel inertia at 0.121 kg·m2
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Flywheel inertia
Number of subjects: 15
Study: 32320566

Group type: EXPERIMENTAL
Intervention: Ruxolitinib (10 mg twice daily)
Number of subjects: 309

Group type: COMPARATOR
Intervention: Control (investigator's choice of therapy)
Number of subjects: 309
Study: 33278856

Group type: EXPERIMENTAL
Intervention: pMDI
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Diskus
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Turbohaler
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Aerolizer
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Handihaler
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Breezhaler
Number of subjects: 180
Study: 32342438

Group type: EXPERIMENTAL
Intervention: Cessation advising by health care practitioners
Number of subjects: 0

Group type: COMPARATOR
Intervention: No advising (control group)
Number of subjects: 0
Study: 35174419

Group type: EXPERIMENTAL
Intervention: Immediate 5-day peer support training
Number of subjects: 100

Group type: COMPARATOR
Intervention: Wait-list control
Number of subjects: 100
Study: 33624821

Group type: EXPERIMENTAL
Intervention: Regions with winter holiday exclusively in week 9
Number of subjects: 219

Group type: COMPARATOR
Intervention: More stringent government response implemented in week 11
Number of subjects: 219
Study: 34689128

Group type: EXPERIMENTAL
Intervention: Cholecalciferol supplementation for 60 days
Number of subjects: 74